 Cellular Biomedicine Group Inc. NASDAQ: CBMG CBMG or the Company, a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, today announced that it will release its financial results for the first quarter ended March 31, 2020 after the market closes on Wednesday, May 6, 2020. 